ليست عنوان مقالات لاتين History of the treatment of childhood ALL: A paradigm for cancer cure Hochschild–Mitchell cohomology and Galois extensions

<< مقالات لاتين >>

<< بر اساس عنوان >>

1

History of the treatment of childhood ALL: A paradigm for cancer cure

2

History of the Triumphs of Our Holy Faith Amongst the Most Barbarous and Fierce Peoples of the New World

3

History of the tuberous sclerosis complex

4

History of the West of Scotland Plastic Surgery Unit: 1940–1986

5

History of thymoma and yellow fever vaccination

6

History of torture

7

History of torture

8

History of treatments

9

History of Tropical Medicine: William Ernest Cooke, FRCSI (1879–1967) and his Asian tour of 1929–1930

10

History of tropospheric ozone for the San Bernardino Mountains of Southern California, 1963–1999

11

History of Tumescent Anesthesia, Part I: From American Surgical Textbooks of the 1920s and 1930s, ,

12

History of umbilical cord blood transplantation

13

History of upper gastrointestinal cancers in relatives: A communitybased estimate

14

History of upwelling in the Tropical Eastern Pacific and the paleogeography of the Isthmus of Panama

15

History of urinary tract infections and risk of renal cell carcinoma

16

History of use and abuse of X-ray: the early 20th century Italian pediatrics school

17

History of water-column anoxia in the Black Sea indicated by pyrite framboid size distributions

18

HISTORY OF WHEAT BREEDING IN LATVIA

19

History on Trial

20

History on Trial

21

History on Wikipedia: In need of a NWICO (New World Information and Communication Order)? the case of Cambodia

22

History plotting tool for Data Quality Monitoring

23

History plotting tool for Data Quality Monitoring

24

History recovery and source identification of multiple gaseous contaminants releasing with thermal effects in an indoor environment

25

History rediscovered: Welcome to 139 years of The Veterinary Journal

26

History repeating

27

History repeating. The plague of 1630 in Milan and the COVID-19 pandemia

28

History repeats itself: The failure of rational choice models in corporate governance

29

History Rewritten in a Postmodern Novel: Opposed Views on History in Jeanette Winterson’s The Passion

30

History Run Wild: The Alternate World of Joan Aiken’s The Wolves of Willoughby Chase Series

31

History through the eyes of the eyes

32

History versus expectations: Increasing returns or social influence?

33

History Writing That’s ‘‘Good to Think With’’: The Great Fire, Blizzard! and An American Plague

34

History, agency and political struggle: a different view

35

History, challenges and perspectives of cell microencapsulation

36

History, chemistry and biology of alkaloids from Lobelia inflata

37

History, collective memory and identity: the Tatars of sovereign Tatarstan

38

History, concept and spectrum of rheumatism, challenges in understanding

39

History, current state, and future of oil/gas industry in Russia. Academy of natural sciences of Russia, Moscow (1995)

40

History, current state, and future of oil/gas industry in Russia. Academy of natural sciences of Russia, Moscow (1995)

41

History, current state, and future of oil/gas industry in Russia. Academy of natural sciences of Russia, Moscow (1995)

42

History, current status, and collaborative research projects for Bemisia tabaci

43

History, development, and a new concept of phthalocyanines in Turkey

44

History, distance and text: narratives of the 1853–1854 Perry expedition to Japan

45

History, meaning, and interpretation: a critical response to Bevir

46

History, memory, and justice: The Touvier trial in France

47

HISTORY, MORPHOLOGY AND PERFECT PROPORTIONS OF MUGHAL TOMBS: THE SECRET TO CREATION OF TAJ MAHAL

48

History, Narrative, and Photography in W. G. Sebalds Die Ausgewanderten

49

History, narrative, and time

50

History, opportunities and challenges for biological control in Australia, New Zealand and the Pacific islands

51

History, origin and extent of soil erosion on Easter Island (Rapa Nui)

52

HISTORY, POLITICS, AND CLAIMS OF MAN-MADE GLOBAL WARMING

53

History, principles, and practice of health and human rights

54

History, Structure and Agency in Global Health Governance; Comment on “Global Health Governance Challenges 2016 – Are We Ready?”

55

History, Studies and Specific Uses of Repetitive Transcranial Magnetic Stimulation (rTMS) in Treating Epilepsy

56

History, the kidney, and hypertension in blacks versus whites

57

History/ Fiction: An Intertextual reading of E. L. Doctorow’s Ragtime

58

History’s Worst Inventions and the People Who Made Them. Chaline, Eric. New Holland Publishers, UK, Ltd. (2009). £10.99, ISBN: 978 1 84773 505 8.

59

History-based price discrimination and entry in markets with switching costs: A welfare analysis

60

History-dependence of isometric muscle force: Effect of prior stretch or shortening amplitude

61

History-dependent magnetic properties in pure and Zn-doped cupric oxide

62

History-dependent modified sliding mode interception strategies with maximal capture zone

63

History-dependent phase slips and rectification of a few coupled oscillators system

64

History-sensitive versus future-sensitive approaches to security in distributed systems

65

History-taking and Preventive Medicine Skills among Primary Care Physicians: An Assessment Using Standardized Patients

66

Histpathological Anti-inflammatory Effects of Flunixin Meglumine and Ketoprofen on Excised Rat Tendon

67

His–Trp cation–π interaction and its structural role in an α-helical dimer of HIV-1 Vpr protein Original Research Article

68

Hit and target models for DNA damage with indirect action

69

Hit covariance formalism for stereo detectors

70

Hit covariance formalism for stereo detectors

71

Hit diabetes hard and early for best long-term results

72

Hit efficiency study of CMS prototype forward pixel detectors

73

Hit efficiency study of CMS prototype forward pixel detectors

74

Hit ʹEm Where They Live: Targeting the Cancer Stem Cell Niche

75

Hit generation and exploration: Imidazo[4,5-b]pyridine derivatives as inhibitors of Aurora kinases

76

Hit harder than HAART

77

Hit HIV-1 hard, but only when necessary Review Article

78

HIT in VAD Patients: Considerations

79

HIT NOISE REDUCTION IN SOME X-RAY IMAGES

80

Hit or miss: branch structure affects perch choice, behaviour, distance and accuracy of brown tree snakes bridging gaps

81

Hit statistics in FH-CDMA unslotted packet networks

82

Hitachi Hemolytic Index correlates with HBOC-201 concentrations: Impact on suppression of analyte results

83

Hitch in implementing Russiaʹs HIV-prevention law

84

Hitch in US product-liability reform for pharmaceuticals

85

Hitches in implementing organ-donation law in Poland

86

Hitchhikers on the fungal highway: The helper effect for bacterial migration via fungal hyphae

87

Hitchhikers on the fungal highway: The helper effect for bacterial migration via fungal hyphae

88

Hitchhiking without Covalent Integration

89

Hitching a ride on a hermit crabs home: Movement of gastropod shells inhabited by hermit crabs

90

Hitchin–Thorpe inequality for noncompact Einstein 4-manifolds

91

Hi-Tech Authentication for Palette Images Using Digital Signature and Data Hiding

92

Hi-tech breast-cancer screening: will it deliver?

93

hITeQ: A new workflow-based computing environment for streamlining discovery. Application in materials science

94

HIT-IIP: an information integrating platform for CIM system based on client/server architecture

95

Hitler, the Germans, and the Final Solution. By Ian Kershaw. New Haven, CT, and London: Yale University Press. 2008.

96

Hitler’s Ethic: The Nazi Pursuit of Evolutionary Progress. By Richard Weikart. New York: Palgrave Macmillan. 2009

97

Hitler’s Generals on Trial: The Last War Crimes Tribunal at Nuremberg. By Valerie Geneviève Hébert. Lawrence, KS: University Press of Kansas. 2010

98

Hitler’s Man in Havana: Heinz Lu¨ning and Nazi Espionage in Latin America. By Thomas D. Schoonover. With a Foreword by Louis A. Perez, Jr. Lexington, KY: University of Kentucky Press. 2008.

99

Hitlers Judenhass. Klischee und Wirklichkeit. By Ralf Georg Reuth. Munich: Piper Verlag. 2009

100

Hitologic and clinical evaluation of combined eyelid erbium:YAG and CO2 laer reurfacing

101

Hitologic Correlation of In Vivo Optical Coherence Tomography Image of the Human Retina

102

Hitologic parameter helpful to recognize teroid-treated temporal arteriti: An analyi of thirty-five cae

103

Hitologic tudy of retiniti pigmentoa due to a mutation in the RP13 gene (PRPC8): comparion with rhodopin Pro23Hi, Cy110Arg, and Glu181Ly

104

Hitology of the vitreoretinal interface after taining of the internal limiting membrane uing glucoe 5% diluted indocyanine and infracyanine green

105

Hitopathologic analyi of 232 eye with retinoblatoma conducted in an Indian tertiary-care ophthalmic center

106

Hitopathologic and immunohitochemical tudy of dominant cone degeneration

107

Hitopathologic and Immunologic Apect of AlphaCor Artificial Corneal Failure Original Reearch Article

108

Hitopathologic characteritic of uveal melanoma in eye enucleated from the collaborative ocular melanoma tudy COM report no. 6 Original Reearch Article

109

Hitopathologic Examination of Conjunctival Tophi in Gouty Arthriti

110

Hitopathologic Finding After Radial Optic Neurotomy in Central Retinal Vein Occluion

111

Hitopathologic tudy of variation in everity of retiniti pigmentoa due to the dominant rhodopin mutation Pro23Hi

112

Hitopathologic tudy of X-linked cone-rod dytrophy (CORDX1) caued by a mutation in the RPGR exon ORF15

113

Hitopathological abnormalitie in ocular blood veel of CADAIL patient

114

Hitopathology of Blepharoptoi Induced by Prolonged Hard Contact Len Wear

115

Hitopathology of the eye in diffue neonatal hemangiomatoi

116

Hitoshi Oshitani: watching out for an influenza pandemic

117

Hitoshi Sakai (1930–2008)

118

Hitox titanium pigment prices raised

119

Hitox titanium pigment prices raised for the second time this year

120

Hits and flops dynamics

121

Hits and misses: crafting a pop single for the top-40 market in the 1960s

122

Hits-and-misses for the evaluation and combination of forecasts

123

Hitting a Nerve: Ion Channels May Hold the Key for Treating Chronic Pain

124

Hitting and returning to rare events for all alpha-mixing processes

125

Hitting from any direction in 3-D space by a robot with a flexible link hammer

126

Hitting H pylori for four

127

Hitting HIV where it hurts: an alternative approach to HIV vaccine design

128

Hitting moving targets: Co-operative control of ‘when’ and ‘where’

129

Hitting of a line or a half-line in the plane by two-dimensional symmetric stable Lévy processes

130

Hitting probabilities and hitting times for stochastic fluid flows

131

HITTING PROBABILITIES AND HITTING TIMES FOR STOCHASTIC FLUID FLOWS THE BOUNDED MODEL

132

Hitting probabilities for non-convex lattice

133

Hitting sets when the VC-dimension is small

134

Hitting Spheres with Brownian Motion and Sommerfeld′s Radiation Condition

135

Hitting the distributed computing sweet spot with Tspaces

136

Hitting the mark or falling short with nanotechnology regulation? Original Research Article

137

Hitting the Target with Bifunctional Phage Review Article

138

Hitting time analysis for a class of random packet forwarding schemes in ad hoc networks

139

Hitting time distributions in financial markets

140

Hitting times for the perturbed reflecting random walk

141

Hitting times of Brownian motion and the Matsumoto–Yor property on trees

142

Hit-to-lead optimization of 1,4-dihydroindeno[1,2-c]pyrazoles as a novel class of KDR kinase inhibitors

143

Hit-to-lead studies on benzimidazole inhibitors of ITK: Discovery of a novel class of kinase inhibitors

144

Hit-to-Lead studies: The discovery of potent adamantane amide P2X7 receptor antagonists

145

Hit-to-lead studies: the discovery of potent, orally active, thiophenecarboxamide IKK-2 inhibitors

146

Hit-to-Lead studies: The discovery of potent, orally bioavailable thiazolopyrimidine CXCR2 receptor antagonists

147

Hit-to-Lead studies: The discovery of potent, orally bioavailable triazolethiol CXCR2 receptor antagonists

148

Hitungan dalam Naskhah Melayu dan Jawa: Analisis dalam Syair Laksana Kita Mujarabat

149

HIV / AIDS health literacy and Its Related Factors: a cross-sectional study

150

HIV “escape” mutants could thwart vaccine development

151

HIV A clever hijacker of the immune system

152

HIV and AIDS among the Severely Mentally Ill: Introduction to the special series

153

HIV and AIDS in southeast Asia

154

HIV and AIDS, poverty, and causation

155

HIV and AIDS-related stigma and discrimination: a conceptual framework and implications for action

156

HIV and autoimmunity

157

HIV and bone disease

158

HIV and cancer of the cervix

159

HIV and Cardiovascular Disease in Sub-Saharan Africa: The Sutton Law as Applied to Global Health

160

HIV and communication

161

HIV and complement: hijacking an immune defense

162

HIV and Coronary Heart Disease: Time for a Better Understanding

163

HIV and depression: context and care: Francisco J. Gonzales; UCSF AIDS Health Project, San Francisco, 2001, 106pp, $11.95 (paper)

164

HIV and diarrhea in the era of HAART: 1998 New York State hospitalizations

165

HIV and exclusive breastfeeding: Just how exclusive and when to stop?

166

HIV and gynaecological infections

167

HIV and hepatitis C virus RNA in seronegative organ and tissue donors

168

HIV and human rights in refugee settings

169

HIV and intimate partner violence among methadone-maintained women in New York City

170

HIV and Islam: is HIV prevalence lower among Muslims?

171

HIV and orientation of subsistence and commercial home gardens in rural Ghana: Crop composition, crop diversity and food security

172

HIV and peacekeeping operations in Cambodia

173

HIV and primary health care: disclosure and discrimination

174

HIV and sexual health in the UK: politics and public health

175

HIV and Sub-Saharan African Women in the COVID-19 Era and beyond

176

HIV and the blood supply: An analysis of crisis decisionmaking : Edited by Lauren B. Leveton, Harold C. Sox Jr, and Michael A. Stoto. Institute of Medicine, National Academy Press, Washington, DC, 1995. 352 pp., $47.95 (cloth)

177

HIV and the cell cycle

178

HIV and the paediatrician as the childʹs advocate

179

HIV and tuberculosis in the former Soviet Union

180

HIV as the cause of AIDS

181

HIV care provider perceptions and approaches to managing unhealthy alcohol use in primary HIV care settings: a qualitative study

182

HIV case shocks USA

183

HIV causes AIDS: Kochʹs postulates fulfilled

184

HIV clearance in infants

185

HIV co-infection with a currently non-pathogenic flagellate

186

HIV co-infection with tuberculous and non-tuberculous mycobacteria in western Kenya: challenges in the diagnosis and management

187

HIV control in Cuba

188

HIV control in vivo: Dynamical analysis

189

HIV controllers: A multifactorial phenotype of spontaneous viral suppression

190

HIV co-receptor identification: good or bad news for drug discovery?

191

HIV Coreceptor Usage and Drug Treatment

192

HIV could blunt progress in China, Clinton warns

193

HIV disclosure and discussions about grief with Shona children: A comparison between health care workers and community members in Eastern Zimbabwe

194

HIV Disclosure by Perinatal Women in Thailand

195

HIV discoverers awarded Nobel Prize for medicine

196

197

HIV disease in the year 2000

198

HIV disease progression and effects of tuberculosis preventive therapy in HIV-infected adults

199

HIV disease progression: depression, stress, and possible mechanisms

200

HIV disease treatment in the era of HAART

201

HIV disease: mucocutaneous fungal infections in HIV disease

202

HIV drug resistance among naïve HIV-infected patients in Iran

203

HIV dynamics: Analysis and robust multirate MPC-based treatment schedules

204

HIV dynamics: Modeling, data analysis, and optimal treatment protocols

205

HIV education for health-care professionals in high prevalence countries: time to integrate a pre-service approach into training

206

HIV education in emergency, conflict, and post-conflict contexts

207

HIV education in the formal curriculum

208

HIV Enters Cells via Endocytosis and Dynamin-Dependent Fusion with Endosomes

209

HIV entry inhibitors

210

HIV Entry Revisited

211

HIV Envelope-CXCR4 Signaling Activates Cofilin to Overcome Cortical Actin Restriction in Resting CD4 T Cells

212

HIV epidemic could number 40 million by year 2000

213

HIV epidemic in Central India: trends over 18 years (1986–2003)

214

HIV epidemic in India

215

HIV epidemic in India: opportunity to learn from the past

216

HIV epidemic in Russia

217

HIV escape from cytotoxic T lymphocytes: a potential hurdle for vaccines?

218

HIV Fusion Peptide Penetrates, Disorders, and Softens T-Cell Membrane Mimics

219

HIV Gag p24 specific responses secreting IFN-γ and/or IL-2 in treatment-naïve individuals in acute infection early disease (AIED) are associated with low viral load

220

HIV gene arrests cell cycle

221

HIV Genetic effects on immunity Immunity to infection Web alert

222

HIV GOVERNANCE THROUGH LAW: ACHIEVEMENTS AND CHALLENGES OF CHINA S LEGAL ENVIRONMENT

223

HIV gp120 V1/V2 and C2-V3 domains glycoprotein compatibility is required for viral replication

224

HIV gp120: double lock strategy foils host defences

225

HIV Health Literacy (HALTRA) Model: A New Model Based on Information and Motivation to Eradicate Social Stigma

226

HIV in central and eastern Europe

227

HIV in England and Wales

228

HIV in Pakistan: An emerging menace

229

HIV in the over-50s in south London

230

HIV incidence among injecting drug users in New York City syringe-exchange programmes

231

HIV Incidence and CDC’s HIV Prevention Budget: An Exploratory Correlational Analysis

232

HIV Indeterminate Western Blot Results in Blood Donors in Northeast of Iran, 2009-2014

233

HIV Infected Young Man with Prolonged Fever and Cough

234

HIV infection and advanced age: Emerging epidemiological, clinical, and management issues

235

HIV infection and chronic hepatitis C

236

HIV infection and high density lipoprotein metabolism

237

HIV infection and high-risk behaviors in opioid dependent patients: The Indian context

238

HIV infection and neoplasia

239

HIV infection and neoplasia

240

HIV infection and neoplasia

241

HIV infection and neoplasia

242

HIV infection and neoplasia

243

HIV infection and related risk behaviours among female sex workers in greater Cairo, Egypt

244

HIV infection and sex in sex-on-premises venues are associated with a higher risk of syphilis reinfection among men who have sex with men

245

HIV Infection and the Dynamic Interplay between the Thymus and the Peripheral T Cell Pool

246

HIV infection from donor semen

247

HIV infection in Cuban women

248

HIV Infection in Iran: An Update on Epidemiology, Testing and Gaps

249

HIV infection of CD8 cells

250

Hiv infection of endothelial cells promotes the development of aids-associated b cell lymphomas

251

HIV infection of mononuclear cells is calcium-dependent

252

HIV infection rates in Japan projected to increase

253

HIV infection reduces skin graft survival in burn injuries: a prospective study

254

HIV Infection, HIV/HCV and HIV/HBV co-infections among Jail Inmates of Lahore

255

HIV infection: first battle decides the war

256

HIV infection: where have all the T cells gone?

257

HIV interaction with endosomes in macrophages and dendritic cells

258

HIV levels in motherʹs blood predicts risk of perinatal transmission

259

HIV levels may predict mother-to-child

260

HIV may produce inhibitory microRNAs (miRNAs) that block production of CD28, CD4 and some interleukins

261

HIV Modes of Transmission in Sudan in 2014

262

HIV myths should not be resuscitated

263

HIV myths should not be resuscitated

264

HIV myths should not be resuscitated – Authorʹs reply

265

HIV nucleoside analogues: new adverse effects on mitochondria?

266

HIV outreach for hard-to-reach populations: a cross-site perspective

267

HIV overshadows South African health advances

268

HIV p17 reverses the anti-inflammatory activity of IL-4 on IL-15 stimulated monocytes and modulates their ability to secrete MIP-1 alpha

269

HIV Patients’ Satisfaction with Services Provided at Tertiary Health Institutions in Ogun East Senatorial District, Ogun State, Nigeria: Public-private Comparison

270

HIV positive women's living experiences

271

HIV postexposure prophylaxis for children and adolescents

272

HIV postexposure prophylaxis in the emergency department: The morning after is today

273

HIV Postexposure Prophylaxis in Victims of Child Sexual Abuse

274

HIV postexposure prophylaxis practices by US ED practitioners

275

HIV Preparing for HIV vaccines that induce cytotoxic T lymphocytes

276

HIV prevalence among men who have sex with men in Iran: A systematic review and meta-analys s

277

HIV Prevalence among Pregnant Women in Eight Provincial Capitals in Indonesia in 2003-2010.

278

HIV prevalence among pregnant women in Kigali, Rwanda

279

HIV prevalence and poverty in Africa: Micro- and macro-econometric evidences applied to Burkina Faso

280

HIV Prevalence and Risk Behaviors among Patients Attending Los Angeles County Tuberculosis Clinics: 1993–1996

281

HIV prevalence and trends in sub-Saharan Africa: no decline and large subregional differences

282

HIV prevention among Zambian adolescents: Developing a value utilization/norm change model

283

HIV prevention and treatment in South Africa: affordable and desirable

284

HIV prevention before HAART in sub-Saharan Africa

285

HIV prevention efforts reach fewer than one in five at risk

286

HIV prevention for intravenous drug users

287

HIV prevention in developed countrie

288

HIV prevention perception among barbers according to health belief model

289

HIV prevention research in a resource-limited setting: the experience of planning a trial in Cambodia

290

HIV prevention research: the ecstasy and the agony

291

HIV prevention, childrens rights, and homosexual youth

292

HIV programme for aid workers in Norway

293

HIV Programs in Iran (Persia), Iraq and Saudi Arabia: A Brief Review of Current Evidence in West and Southwest Asia

294

HIV Prophylaxis in High Risk Newborns: An Examination of Sociodemographic Factors in an Inner City Context

295

HIV protease inhibitor HOE/BAY 793, structure-activity relationships in a series of C2-symmetric diols Original Research Article

296

HIV protease inhibitor Lopinavir induces apoptosis of primary effusion lymphoma cells via suppression of NF-κB pathway

297

HIV protease inhibitors block oral epithelial cell DNA synthesis

298

HIV protease inhibitors have specific anti-cancer effects

299

HIV protease inhibitors increase TNF-α and IL-6 expression in macrophages: Involvement of the RNA-binding protein HuR

300

HIV protease inhibitors with picomolar potency against PI-Resistant HIV-1 by extension of the P3 substituent

301

HIV quantification: clinical applications

302

HIV quantification: useful for prediction of vertical transmission?

303

HIV Rapid Diagnostic Test Inventories in Zambézia Province, Mozambique: A Tale of 2 Test Kits

304

HIV Recent advances in AIDS research: genetics, molecular biology and immunology

305

HIV research: a need to focus on the right target

306

HIV Responses in Arab States on the Southern Persian Gulf Border: The First Review

307

HIV Rev self-assembly is linked to a molten-globule to compact structural transition Original Research Article

308

HIV risk behavior among adults with severe mental illness: A systematic review

309

Hiv risk behavior among alcoholic inpatients before and after treatment

310

HIV risk environment for Ghanaian women: challenges to prevention

311

HIV risk networks and HIV transmission among injecting drug users

312

HIV risk perception and sexual behaviors among female sex workers in Tehran, Iran

313

HIV risk reduction among injection drug users: explaining the lack of anticipated outcomes in a community-level controlled comparison study

314

HIV risk reduction for the seriously mentally ill: Pilot investigation and call for research

315

HIV risk reduction interventions for persons with severe mental illness

316

HIV risk-reduction in adolescents

317

HIV risks among homeless men differentiated by cocaine use and psychiatric distress

318

HIV risks in incarcerated injection-drug users

319

HIV screening of blood transfusions in Zambia

320

HIV self-testing: a time to revise current policy

321

HIV SEROPOSITIVITY IN CHILDREN WITH SICKLE CELL DISEASE

322

HIV Seroprevalence among Newly Incarcerated Inmates in the Texas Correctional System

323

HIV seroprevalence among people with severe mental illness in the United States: A critical review

324

HIV seroprevalence by anonymous testing in patients with Mycobacterium tuberculosis and in tuberculosis contacts

325

HIV serostatus and factors related to physical and mental well-being in Latina family AIDS caregivers

326

HIV status disclosure and partner discordance: A public health dilemma

327

HIV Stigma among People Living with HIV in Southeast Iran

328

HIV stigma: perceptions from HIV-positive and HIV-negative patients in a community dental clinic

329

HIV strategically targets HIV-specific T cells

330

HIV superinfection: another reason to avoid serosorting practice

331

HIV test results, partner notification, and personal conduct

332

HIV Testing among Men Who Have Sex with Men—Results of a Telephone Survey

333

HIV testing and human rights

334

HIV testing history among gay/bisexual men recruited in Barcelona: Evidence of high levels of risk behavior among self-reported HIV+ men

335

HIV testing in developing countries

336

HIV testing in prison

337

HIV Testing in the Emergency Department: Pretest Counseling or Pretest Education?

338

HIV testing over Easter

339

HIV testing: Should the emergency department take part?

340

HIV testing: the mutual rights and responsibilities of partners

341

HIV tests for babies to be mandatory in USA

342

HIV The immune response

343

HIV time hierarchy: winning the war while, loosing all the battles

344

HIV transmission by donor semen

345

HIV transmission by transplantation of allograft skin: a review of the literature

346

HIV transmission from surrogate breastfeeding

347

HIV transmission through health care in sub-Saharan Africa

348

HIV transmission through health care in sub-Saharan Africa

349

HIV transmission through health care in sub-Saharan Africa

350

HIV transmission under highly active antiretroviral therapy

351

HIV transmission under highly active antiretroviral therapy – Authorsʹ reply

352

HIV treatment cascade among female entertainment and sex workers in Cambodia: impact of amphetamine use and an HIV prevention program

353

HIV treatment in South Africa: overcoming impediments to get started

354

HIV treatment in South African children

355

HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis

356

HIV treatment, injection drug use, and illicit drug policies

357

HIV vaccine fails in phase 3 trial

358

HIV vaccine: how long must we wait?

359

HIV vaccine: how long must we wait?

360

HIV vaccines: where we are and where we are going

361

HIV voluntary counselling and testing in community health services

362

HIV, confidentiality, gender, and support in rural South Africa

363

HIV, EBV and KSHV: Viral cooperation in the pathogenesis of human malignancies

364

HIV, fatal rotavirus infection, and treatment options

365

HIV, fatal rotavirus infection, and treatment options

366

HIV, Hepatitis B and Hepatitis C in garbage scavengers of Karachi

367

HIV, occupational exposure, and medical responsibilities

368

HIV/AIDS Among Injecting Drug Users: A review on Epidemiology and Management of Occupational Exposure in Iranian Health Network Setting

369

HIV/AIDS and access to water: A case study of home-based care in Ngamiland, Botswana

370

HIV/AIDS and community conflict in Nigeria: implications and challenges

371

HIV/AIDS and Education: a study on how a selection of school governing bodies in Mpumalanga understand, respond to and implement legislation and policies on HIV/AIDS

372

HIV/AIDS and Farms’ Production Efficiency in Benue State, Nigeria

373

HIV/AIDS and human rights

374

HIV/AIDS and its impact on student nurses

375

HIV/AIDS and people with disability

376

HIV/AIDS AND SHIFTING URBAN CHINA S SOCIOMORAL LANDSCAPE: ENGENDERING BIO-ACTIVISM AND RESISTANCE THROUGH STORIES OF SUFFERING

377

HIV/AIDS and the construction of Sub-Saharan Africa: Heuristic lessons from the social sciences for policy

378

HIV/AIDS AND WELL-BEING IN SOUTH CENTRAL AND SOUTH-EAST ASIA

379

HIV/AIDS Awareness Study of Fresh Students in Tertiary Institutions in Rivers State of Nigeria

380

HIV/AIDS cases in 1999 set to keep increasing into the next century

381

HIV/AIDS conference highlights Lesothoʹs progress

382

HIV/AIDS control in India

383

HIV/AIDS Counseling Skills and Strategies: Can Testing and Counseling Curb the Epidemic?

384

HIV/AIDS data in South Africa

385

HIV/AIDS data in South Africa

386

HIV/AIDS Disease: Transmission Transition

387

HIV/AIDS dynamics: Impact of economic classes with transmission from poor clinical settings

388

HIV/AIDS education among incarcerated youth

389

HIV/AIDS epidemic features and trends in Saudi Arabia

390

HIV/AIDS epidemiology

391

HIV/AIDS epidemiology, pathogenesis, prevention, and treatment

392

HIV/AIDS estimates and the quest for universal access

393

HIV/AIDS explosion in Russia triggers research boom

394

HIV/AIDS Good News and Bad News

395

HIV/AIDS harm reduction in Iran

396

HIV/AIDS High Risk Behaviors and Necessity of Prevention in the Population of Birjand, East of Iran 2013 to 2014: A Population-Based Study

397

HIV/AIDS High Risk Behaviors and Necessity of Prevention in the Population of Birjand, East of Iran 2013 to 2014: A Population-Based Study

398

HIV/AIDS in Africa

399

HIV/AIDS IN AFRICA IN CONTEXT

400

HIV/AIDS in Africa, 2002

401

HIV/AIDS in Asia

402

HIV/AIDS in children: a disaster in the making

403

HIV/AIDS in China: the numbers problem

404

HIV/AIDS in our Midst and Minds

405

HIV/AIDS in South Africa

406

HIV/AIDS in the last 10 years

407

HIV/AIDS IN XINJIANG: A SERIOUS ILL IN AN AUTONOMOUS REGION

408

HIV/AIDS infection control enforcement: a comparison between Nigeria and the United States

409

HIV/AIDS Information Awareness among Market Women: A Study of Olofimuyin Market, Sango-Ota, Ogun State, Nigeria

410

HIV/AIDS information outreach: a community-based approach

411

HIV/AIDS information overload

412

HIV/AIDS institutional discrimination in Switzerland

413

HIV/AIDS issues take centre-stage at World Health Assembly

414

HIV/AIDS knowledge among undergraduate university students: implications for health education programs in Ghana

415

HIV/AIDS Knowledge and Attitude among High School Students in Shiraz, Iran in 2015

416

HIV/AIDS Knowledge and attitudes of Southern Iranian students

417

HIV/AIDS knowledge, attitudes and beliefs among a group of Iraqis

418

HIV/AIDS lowers UNʹs global population estimates

419

HIV/AIDS Monitoring and Evaluation Systems Strengthening for the National AIDS Program in Albania

420

HIV/AIDS policy agenda setting in Iran

421

HIV/AIDS prevention and treatment

422

HIV/AIDS prevention and treatment

423

HIV/AIDS prevention and treatment

424

HIV/AIDS prevention and treatment

425

HIV/AIDS prevention and treatment

426

HIV/AIDS prevention and treatment

427

HIV/AIDS Prevention Factors from Contagious Risk Behavior Among Middle School Students

428

HIV/AIDS prevention for migrants and ethnic minorities: three phases of evaluation

429

HIV/AIDS Preventive Education amongst Biology Teachers: Assessing Knowledge and Attitudinal Change

430

HIV/AIDS Related Stigma in Iran: A Qualitative Study

431

HIV/AIDS research in India: A bibliometric study

432

HIV/AIDS Risk Behaviours Among Injecting Drug Users: Addressing Development of Risk Behaviour Knowledge and Patterns of Risk Behaviour Practices in Context of Demographic Characteristics

433

HIV/AIDS Situation in Economic Cooperation Countries; Achievement and Gaps toward Millennium Development Goals

434

HIV/AIDS surveillance in Egypt: current status and future challenges

435

HIV/AIDS treatment and HIV vaccines for Africa

436

HIV/AIDS vulnerability of Nepali migrants to India: whose concern?

437

HIV/AIDS, artisanal fishing and food security in the Okavango Delta, Botswana

438

HIV/AIDS, gender, agency and empowerment issues in Africa

439

HIV/AIDS, human capital, and economic growth prospects for Mozambique

440

HIV/AIDS. A Guide to Nursing Care, 3rd edn., J.H. Flaskerud, P. Unguarski. W B Saunders, Switzerland (1995), ISBN: 0 7216 5239 5

441

HIV/AIDS: A Cross-cutting Theme in Human Rights –Domestic and International Dimensions

442

HIV/AIDS: Global Frontiers in Prevention/Intervention, C. Pope, R.T. White, R. Malow (Eds.). Routledge, New York (2008). 572 p., paperback US$49.95, ISBN: 978-0-415-95383-2.

443

HIV/AIDS: in search of an animal model Original Research Article

444

HIV/AIDS: the private sector is vital

445

HIV/AIDS—An issuein nurse education

446

HIV/AIDS-Associated Stigma Among Afro-Caribbean People Living in the United States

447

HIV/AIDS—call for papers

448

HIV/AIDS—call for papers

449

HIV/AIDS-related social anxieties in adolescents in three African countries

450

HIV/AIDS-related stigma and discrimination: Accounts of HIV-positive Caribbean people in the United Kingdom

451

HIV/HBV Co-Infections: Epidemiology, Natural History, and Treatment: A Review Article

452

HIV/HCV coinfection, HAART, and liver-related mortality

453

HIV/HCV coinfection, HAART, and liver-related mortality

454

HIV/STD-Protective Benefits of Living with Mothers in Perceived Supportive Families: A Study of High-Risk African American Female Teens

455

HIV: An Epidemiologic study on Head and Neck Involvement in 50 Patients

456

HIV: Immunity to infection. Genetic effects on immunity: Web alert

457

HIV: Medical Milestones and Clinical Challenges

458

HIV: Pre-exposure Prophylaxis

459

HIV: T cell responses to HIV: Editorial overview

460

HIV: the other dimension

461

HIV: Ufff…I Got a Needle Prick

462

HIV-1 and AIDS awareness in a marginalised Namibian community

463

HIV-1 and hepatitis B virus: time for a re-think?

464

HIV-1 and immune control: can we change the course of HIV-1?

465

HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers

466

HIV-1 and scrub-typhus

467

HIV-1 and tuberculosis infection

468

HIV-1 and tuberculosis infection

469

470

HIV-1 biological phenotype and predicted coreceptor usage based on V3 loop sequence in paired PBMC and plasma samples

471

HIV-1 care in resource-poor settings: a view from Haiti

472

HIV-1 Coreceptor Selectivity: Structural Analogy between HIV-1 V3 Regions and Chemokine β-Hairpins Is Not the Explanation

473

HIV-1 disease progression and AIDS-defining disorders in rural Uganda

474

HIV-1 diversity versus HLA class I polymorphism

475

HIV-1 DNA vaccine shows promise in chimpanzees

476

HIV-1 drug resistance reported in Brazil

477

HIV–1 dynamics at different time scales under antiretroviral therapy

478

HIV-1 Envelope Glycoprotein Biosynthesis, Trafficking, and Incorporation Review Article

479

HIV-1 fusion mechanism could be target for new drugs

480

HIV-1 Gag Extension: Conformational Changes Require Simultaneous Interaction with Membrane and Nucleic Acid

481

HIV-1 Genome Nuclear Import Is Mediated by a Central DNA Flap

482

HIV-1 gp120-induced sickness behavior is exacerbated in aged mice: Is this exaggerated sickness behavior potentially mediated through a pathway involving the up-regulation of CXCR4?

483

HIV-1 group O and group M dual infection in Bénin

484

HIV-1 group O and group M dual infection in Bénin

485

HIV-1 group O infection identified in USA

486

HIV-1 group O infection in the USA

487

HIV-1 immunopathogenesis: How good interferon turns bad

488

HIV-1 in injecting-drug users and heterosexuals

489

HIV-1 in semen: an isolated virus reservoir

490

HIV-1 in Taiwan

491

HIV-1 incidence and prevalence trends in Uganda

492

HIV-1 incidence and prevalence trends in Uganda

493

HIV-1 incidence in sub-Saharan Africa

494

HIV-1 induced decrease of nitric oxide production and inducible nitric oxide synthase expression during in vivo and in vitro infection

495

HIV-1 infected patients with toxic epidermal necrolysis: an occupational risk for healthcare workers

496

HIV-1 infection and intraepithelial neoplasia of lower genital tract

497

HIV-1 infection and malaria parasitaemia

498

HIV-1 infection and malaria parasitaemia

499

HIV-1 infection and malaria parasitaemia

500

HIV-1 infection and malaria parasitaemia

501

HIV-1 infection and prostitutes

502

HIV-1 infection and risk of tuberculosis after rifampicin treatment

503

HIV-1 infection and risk of tuberculosis after rifampicin treatment

504

HIV-1 infection and risk of vulvovaginal and perianal condylomata acuminata and intraepithelial neoplasia: a prospective cohort study

505

HIV-1 infection and the female genital tract

506

HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis

507

HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis

508

HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis

509

HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis

510

HIV-1 infection by artificial insemination

511

HIV-1 infection in a man homozygous for CCR5▭∆32

512

HIV-1 infection in an individual homozygous for CCR5▭∆32

513

HIV-1 infection in China

514

HIV-1 infection in commercial plasma donors in China

515

HIV-1 infection in foreign nationals working in East Timor

516

HIV-1 Infection Induces Acetylation of NPM1 That Facilitates Tat Localization and Enhances Viral Transactivation

517

HIV-1 infection initiates changes in the expression of a wide array of genes in U937 promonocytes and HUT78 T cells

518

HIV-1 infection kinetics in tissue cultures

519

HIV-1 infection puzzles Denmark

520

HIV-1 infection rapidly alters cell gene expression

521

HIV-1 integrase pharmacophore model derived from diverse classes of inhibitors

522

HIV-1 Integrase Strand Transfer Inhibitors Stabilize an Integrase–Single Blunt-Ended DNA Complex

523

HIV-1 Integration in the Human Genome Favors Active Genes and Local Hotspots

524

HIV-1 long terminal repeat modulation by glucocorticoids in monocytic and lymphocytic cell lines

525

HIV-1 Matrix Protein Binding to RNA

526

HIV-1 matrix protein: A mysterious regulator of the viral life cycle

527

HIV-1 Nef associates with p22-phox, a component of the NADPH oxidase protein complex

528

HIV-1 Nef Dimerization Is Required for Nef-Mediated Receptor Downregulation and Viral Replication

529

HIV-1 Nef Downregulates MHC-I by a PACS-1- and PI3K-Regulated ARF6 Endocytic Pathway

530

HIV-1 nucleocapsid protein activates transient melting of least stable parts of the secondary structure of TAR and its complementary sequence

531

HIV-1 Nucleocapsid Protein as a Nucleic Acid Chaperone: Spectroscopic Study of its Helix-destabilizing Properties, Structural Binding Specificity, and Annealing Activity

532

HIV-1 Nucleocapsid Protein Binds to the Viral DNA Initiation Sequences and Chaperones their Kissing Interactions

533

HIV-1 Nucleocapsid Protein Switches the Pathway of Transactivation Response Element RNA/DNA Annealing from Loop–Loop “Kissing” to “Zipper”

534

HIV-1 nucleocapsid protein zinc finger structures induce tRNALys,3 structural changes but are not critical for primer/template annealing

535

HIV-1 p17 binds heparan sulfate proteoglycans to activated CD4+ T cells

536

HIV-1 peripheral neuropathy and combination antiretroviral therapy

537

HIV-1 prevalence in young adults in south India

538

HIV-1 prevalence in young adults in south India

539

HIV-1 prevalence in young adults in south India

540

HIV-1 prevalence in young adults in south India

541

HIV-1 prevalence in young adults in south India

542

HIV-1 prevalence in young adults in south India – Authorsʹ reply

543

HIV-1 prevention in the context of increasing access to treatment

544

HIV-1 progression in hepatitis-C-infected drug users

545

HIV-1 progression in hepatitis-C-infected drug users

546

HIV-1 progression in hepatitis-C-infected drug users

547

HIV-1 progression in hepatitis-C-infected drug users

548

HIV-1 Protease Dimer Interface Mutations that Compensate for Viral Reverse Transcriptase Instability in Infectious Virions

549

HIV-1 protease inhibitors containing an N-Hydroxyamino acid core structure Original Research Article

550

HIV-1 protease inhibitors with picomolar potency against PI-resistant HIV-1 by modification of the P1′ substituent

551

HIV-1 Proteinase as Structural Model of Intercellular Transport Proteins of Plant Viruses

552

HIV-1 reactivation in HIV-latently infected dendritic cells by oral microorganisms and LPS

553

HIV-1 Replication and Latency Are Regulated by Translational Control of Cyclin T1

554

HIV-1 Replication in Monocyte-derived Dendritic Cells is Stimulated by Melarsoprol, One of the Main Drugs Against Human African Trypanosomiasis

555

HIV-1 replication in patients with undetectable plasma virus receiving HAART

556

HIV-1 replication inhibitors of the styrylquinoline class: incorporation of a masked diketo acid pharmacophore

557

HIV-1 replication inhibitors of the styrylquinoline class: introduction of an additional carboxyl group at the C-5 position of the quinoline

558

HIV-1 researchers talk cautiously of a good year

559

HIV-1 Reverse Transcriptase Can Simultaneously Engage Its DNA/RNA Substrate at Both DNA Polymerase and RNase H Active Sites: Implications for RNase H Inhibition

560

HIV-1 Reverse Transcriptase Dissociates during Strand Transfer

561

HIV-1 reverse transcriptase inhibitor resistance mutations and fitness: A view from the clinic and ex vivo

562

HIV-1 reverse transcription initiation: A potential target for novel antivirals?

563

HIV-1 Reverse Transcription: A Brief Overview Focused on Structure–Function Relationships among Molecules Involved in Initiation of the Reaction

564

HIV-1 RNA and CD4+ counts to predict the risk of AIDS

565

HIV-1 RNA serum-load and resistant viral genotypes during early zidovudine therapy

566

HIV-1 Sequence Variation: Drift, Shift, and Attenuation

567

HIV-1 seroprevalence rates in women and relinquishment of infants to the state in St Petersburg, Russia, 2002

568

HIV-1 serum RNA load and resistance during early ZDV therapy

569

HIV-1 shedding in genital tract of infected women

570

HIV-1 shedding in genital tract of infected women

571

HIV-1 shedding in genital tract of infected women

572

HIV-1 specific CD8+ T cells with an effector phenotype and control of viral replication

573

HIV-1 statistics bring good news for Uganda

574

HIV-1 subtype B in Honduras

575

HIV-1 subtype B in West Africa

576

HIV-1 subtype C in China

577

HIV-1 subtypes and circulating recombinant forms (CRFs) in Northern Greece

578

HIV-1 subtypes and male-to-female transmission in Thailand

579

HIV-1 subtypes in different risk groups in South Africa

580

HIV-1 suppression by early treatment with hydroxyurea, didanosine, and a protease inhibitor

581

HIV-1 suppression during acute scrub-typhus infection

582

HIV-1 Tat increases the adhesion of monocytes and T-cells to the endothelium in vitro and in vivo: implications for AIDS-associated vasculopathy

583

HIV-1 Tat interaction with cyclin T1 represses mannose receptor and the bone morphogenetic protein receptor-2 transcription

584

HIV-1 Tat Protects CD4+ Jurkat T Lymphoblastoid Cells from Apoptosis Mediated by TNF-Related Apoptosis-Inducing Ligand

585

HIV-1 Tat Protein and Its Inhibitor Ro 24-7429 Inhibit Lymphocyte Proliferation and Induce Apoptosis in Peripheral Blood Mononuclear Cells from Healthy Donors

586

HIV-1 Tat protein induces IL-10 production by an alternative TNF-α-independent pathway in monocytes: Role of PKC-δ and p38 MAP kinase

587

HIV-1 Tat protein induces TNF-α and IL-10 production by human macrophages: Differential implication of PKC-βII and -δ isozymes and MAP kinases ERK1/2 and p38

588

HIV-1 Tat vaccines

589

HIV-1 Tat: coping with negative elongation factors

590

HIV-1 Tat-mediated protein transduction of Cu,Zn-superoxide dismutase into pancreatic β cells in vitro and in vivo

591

HIV-1 therapy and fetal mitochondrial dysfunction

592

HIV-1 trans-Activating (Tat) Protein BOTH A TARGET AND A TOOL IN THERAPEUTIC APPROACHES

593

HIV-1 Transcription: Activation Mediated by Acetylation of Tat

594

HIV-1 transforms the monocyte plasma membrane proteome

595

HIV-1 transmission during scintigraphy

596

HIV-1 transmission through artificial insemination

597

HIV-1 transport across the blood–brain barrier is enhanced by lipopolysaccharide

598

HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysis

599

HIV-1 vaccines and the nef story so far

600

HIV-1 viral load and scrub typhus

601

HIV-1 viral load and scrub typhus

602

HIV-1 viral load and scrub typhus

603

HIV-1 viral load, phenotype, and resistance in a subset of drug-naive participants from the Delta trial

604

HIV-1 Viral RNA Is Selected in the Form of Monomers that Dimerize in a Three-step Protease-dependent Process; the DIS of Stem–Loop 1 Initiates Viral RNA Dimerization

605

HIV-1 Vpr binding to HIV-1 LTR C/EBP cis-acting elements and adjacent regions is sequence-specific

606

HIV-1, antiretroviral therapy, and malaria

607

HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS)

608

HIV-1, the brain, and combination therapy

609

HIV-1/AIDS and maternal and child health in Africa

610

HIV-1/AIDS and the control of other infectious diseases in Africa

611

HIV-1/HIV-2 co-infection among voluntary counselling and testing subjects at a regional hospital in Cameroon

612

HIV-1: hitching a ride on erythrocytes

613

HIV-1-associated nephropathy and response to highly-active antiretroviral therapy

614

HIV-1c vaccine trial planned for South Africa

615

HIV-1-mediated syncytium formation promotes cell-to-cell transfer of Tax protein and HTLV-I gene expression

616

HIV-1-resistance mechanisms continue to unravel

617

HIV-1-resistance phenotype conferred by combination of two separate inherited mutations of CCR5 gene

618

HIV-1-resistant individuals may lack HIV-1 coreceptor

619

HIV-1-vaccine-trial go-ahead reawakens ethics debate

620

HIV-2 and T cell recognition

621

HIV-associated adipose redistribution syndrome as a selective autonomic neuropathy

622

HIV-associated cardiovascular complications: a new challenge for emergency physicians

623

HIV-associated diarrhoea and wasting

624

HIV-associated diarrhoea and wasting : Report of a meeting at the University of Texas Medical School at Houston

625

HIV-associated immune complex glomerulonephritis with lupus-like features

626

HIV-associated lymphoma successfully treated with peripheral blood stem cell transplantation

627

HIV-Associated Nephropathy in the Era of Antiretroviral Therapy

628

HIV-associated neurosyphilis: Report of a fatal case due to fear of work-place stigma

629

HIV-associated respiratory disease

630

HIV-associated respiratory disease

631

HIV-associated respiratory disease

632

HIV-associated respiratory diseases

633

HIV-contamination scare adds to US gene researchersʹ woes

634

HIV-Derived Lentiviral Vectors: Current Progress toward Gene Therapy and DNA Vaccination

635

Hive: distributed agents for networking things

636

HIVE: Helping Interdisciplinary Vocabulary Engineering

637

HIV-Encephalopathy as initial manifestation of acquired immunodeficiency Syndrome in Yucatلn State, Mexico

638

HIV-I TAT Inhibits PKR Activity by Both RNA-Dependent and RNA-Independent Mechanisms

639

HIV-Induced Syncytia in Peripheral Blood Cell Cultures Crawl by Extending Giant Pseudopods

640

HIV-infected healthcare workers: results from a straw poll

641

HIV-infected women in ART programmes

642

HIV-infected women: Barriers to AZT use

643

HIV-integrase aptamer folds into a parallel quadruplex: A thermodynamic study Original Research Article

644

HIV-l and the microRNA-guided silencing pathway: An intricate and multifaceted encounter

645

HIV-negative patient with HHV-8 DNA follicular B-cell lymphoma associated with Kaposiʹs sarcoma

646

HIVNET nevirapine trials

647

HIVNET nevirapine trials

648

HIVNET nevirapine trials

649

HIVNET nevirapine trials

650

HIVNET nevirapine trials

651

HivNet: Studying in Depth the Morphology of HIV-1 Virion Using Deep Learning

652

HIV-positive mothers in Uganda resort to breastfeeding

653

HIV-Positive Patients: Dental Management Considerations

654

HIV-positive people, risk and sexual behaviour

655

HIV-positive servicemen in USA face discharge

656

HIV-prevention strategies

657

HIV-prevention strategies

658

HIV-related knowledge and AIDS stigma among college students in Yemen

659

HIV-Related Knowledge and Stigma Among the General Population in the Southeast of Iran

660

HIV-related lipodystrophy and facial lipoatrophy: The role of Restylane SubQ in reversing facial wasting

661

HIV-related lipodystrophy and related factors

662

HIV-related oral disease

663

HIV-Related Oral Lesions, Demographic Factors, Clinical Staging and Anti-Retroviral Use

664

HIV-related sexual behaviour among migrants and non-migrants in a rural area of China: Role of rural-to-urban migration

665

HIV-related sexual risk assessment among Asian/Pacific Islander American Women: an inductive model

666

HIV-related skin diseases

667

HIV-related skin diseases

668

HIV-related skin diseases

669

HIV-related skin diseases

670

HIV-Related Stigma Among Healthcare Providers in Different Healthcare Settings: A Cross-Sectional Study in Kerman, Iran

671

HIV-related stigma and discrimination: a study of health care workers in Banda Aceh, Indonesia

672

HIV-related stigma: Adapting a theoretical framework for use in India

673

HIV-related thrombocytopenia

674

HIV-specific CD4+ T cells and viremia: whoʹs in control?

675

HIV-specific immunity in HIV-discordant heterosexual couples

676

HIV-vaccine research takes one step forward … and one step back

677

HIWI2 rs508485 Polymorphism Is Associated with Non-obstructive Azoospermia in Iranian Patients

678

HIx concentration by electro-electrodialysis using stacked cells for thermochemical water-splitting IS process

679

HIx system thermodynamic model for hydrogen production by the Sulfur–Iodine cycle

680

Hiyama coupling reaction of fluorous alkenyl-fluorosilanes: Scope and mechanistic considerations

681

Hiyama reaction of aryl bromides with arylsiloxanes catalyzed by a reusable palladium(II)/cationic bipyridyl system in water

682

HJA (1921–2008)

683

Hjálmar Vilhjálmsson (September 25, 1937–August 20, 2011)

684

Hjelmslev planes over nearrings Original Research Article

685

Hjørlandʹs critique of batesʹ work on defining information

686

Hjrat aur Pakistan Mein Doosray Sheher

687

HJURP Is a Cell-Cycle-Dependent Maintenance and Deposition Factor of CENP-A at Centromeres

688

HJWFTAC: software for Hantush–Jacob analysis of variable-rate, multiple-extraction well pumping tests

689

HK97 Maturation Studied by Crystallography and H/2H Exchange Reveals the Structural Basis for Exothermic Particle Transitions

690

H-kernels by walks in subdivision digraph

691

HKR theorem for smooth S-algebras

692

HKT and OKT geometries on soliton black hole moduli spaces Original Research Article

693

HKT geometry and de Sitter supergravity Original Research Article

694

HKUST-1 as an efficient and reusable heterogeneous catalyst for synthesis of 1,4-dihydropyridine at room temperature

695

HL 752: A potent and long-acting antispasmodic agent Original Research Article

696

HL Aurigae: A pre-contact binary system with a solar-mass companion

697

H–L curve: A novel 2D graphical representation for DNA sequences

698

HL-2A control system and its discharge management

699

HL-60 cells degrade α-actinin to produce a fragment that promotes monocyte/macrophage maturation

700

HL7 Messaging Engine with Customizable Translation System

701

HLA and AIDS: a cautionary tale

702

HLA and autoimmune diseases: Type 1 diabetes (T1D) as an example

703

HLA and inflammatory bowel disease

704

HLA and KIR polymorphisms affect NK-cell anti-tumor activity

705

HLA and natural history of HIV infection

706

HLA AND RISK OF ACUTE GRAFT VERSUS HOST DISEASE IN ALLOGENEIC BONE MARROW TRANSPLANTATION FROM AN HLA-IDENTICAL SIBLING

707

HLA antigen frequencies in end-stage idiopathic and ischaemic cardiomyopathy

708

HLA antigens and inflammatory bowel disease in a sample of Iraqi patients

709

HLA antigens in an Omani population with dilated cardiomyopathy

710

HLA antigens in patients with interferon-α-induced autoimmune thyroid disorders in chronic hepatitis C

711

HLA antigens in patients with variant angina in Japan

712

HLA antigens in schizophrenia and mood disorders

713

HLA association with autoimmune disease: restricted binding or T-cell selection?

714

HLA associations in type 1 diabetes: merging genetics and immunology

715

HLA B44 is associated with decreased severity of autoimmune lymphoproliferative syndrome in patients with CD95 defects (ALPS type Ia)

716

HLA based architecture for molecular communication simulation

717

HLA Class I Allele Frequencies in Southern Iranian Women with Breast Cancer

718

HLA Class I and Class II Genes Distribution of the Sistanis in Iran

719

HLA class I and II antigens expression in patients with renal cell carcinoma

720

HLA class I and II polymorphisms in Mexican Mestizo patients with dengue fever

721

HLA class I antigen expression in malignant cells: why does it not always correlate with CTL-mediated lysis?

722

HLA Class I Expression on Human Ovarian Carcinoma Cells Correlates with T-Cell Infiltrationin Vivoand T-Cell Expansionin Vitroin Low Concentrations of Recombinant Interleukin-2

723

HLA Class I Gene Polymorphism in Iranian Patients with Papillon-Lefevre Syndrome

724

HLA class I specific inhibitory receptors

725

HLA class I, II & III genes in confirmed late-onset Alzheimer’s disease

726

HLA Class II Allele and Haplotype Frequencies in Iranian Patients with Acute Myelogenous Leukemia and Control Group

727

HLA Class II Allele and Haplotype Frequencies in Iranian Patients with Leukemia

728

HLA class II alleles and genetic predisposition to the antiphospholipid syndrome

729

HLA class II and antibody responses to circumsporozoite protein repeats of P. vivax (VK210, VK247 and P. vivax-like) in individuals naturally exposed to malaria

730

HLA class II and autoimmunity: Epitope selection vs differential expression

731

HLA class II association with autoimmune hepatitis in Latin America: A meta-analysis

732

HLA class II DNA typing in Buergerʹs disease

733

HLA class II favors clearance of HCV infection and progression of the chronic liver damage

734

HLA class II Genetic Diversity in Arabs and Jews of Iran

735

HLA class II genotype, HLA-DR B cell surface expression and allergen specific IgE production in atopic and non-atopic members of asthmatic family pedigrees

736

HLA class II homozygosity confers susceptibility to common variable immunodeficiency (CVID)

737

HLA Class II influences humoral autoimmunity in patients with type 2 autoimmune hepatitis

738

HLA class II involvement in HIV-associated Toxoplasmic encephalitis development

739

HLA Class II Molecule Signal Transduction Leads to either Apoptosis or Activation via Two Different Pathways

740

HLA class II polymorphism in Latin American patients with multiple sclerosis

741

HLA Class I-Restricted and Tumor-Specific Cytotoxic T Lymphocytes from Metastatic Lymph Nodes of Esophageal Cancers

742

HLA DR/DQ type in a Malay population in Kelantan, Malaysia

743

HLA DR11 and DR12 in chronic hepatitis C: reply to Zavaglia et al.

744

HLA DRB5*01 Association Survey with Multiple Sclerosis in Khuzestan Province of Iran

745

HLA expression and immunologic propertiesof differentiated and undifferentiated mesenchymal stem cells

746

HLA Genes in Atlantic Celtic populations: Are Celts Iberians?

747

HLA genes in Chimila Amerindians (Colombia), the Peopling of America and Medical implications

748

HLA genomics in the third millennium

749

HLA haplotype A*03-B*07 in hemochromatosis probands with HFE C282Y homozygosity: frequency disparity in men and women and lack of association with severity of iron overload

750

HLA in breast cancer: its relevance for immunotherapy

751

HLA in French patients with variant Creutzfeldt-Jakob disease

752

HLA matching and outcome of heart transplantation

753

HLA MATCHMAKER: A MOLECULARLY BASED ALGORITHM FOR HISTOCOMPATIBILITY DETERMINATION

754

HLA Polymorphism in a Sample of Iraqi Acute Lymphoid Leukemia Patients

755

HLA PROFILE AND CLINICAL PRESENTATION OF MULTIPLE SCLEROSIS IN IRAN

756

HLA specificity and kidney transplantation

757

HLA supertypes and supermotifs: a functional perspective on HLA polymorphism

758

HLA tetramer-based artificial antigen-presenting cells for stimulation of CD4+ T cells

759

HLA typing from Serology to Sequencing Era

760

HLA typing in chronic type B, D and C hepatitis

761

HLA typing in Taiwanese patients with oral squamous cell carcinoma

762

HLA_ACTOR_REPAST: An approach to distributing RePast models for high-performance simulations

763

HLA-A and CTGB33 polymorphisms and variation in IQ scores

764

HLA-A Locus-Restricted and Tumor-Specific CTLs in Tumor-Infiltrating Lymphocytes of Patients with Non-Small Cell Lung Cancer

765

HLA-A*26 and Susceptibility of Iranian Patients with Non-Hodgkin Lymphoma

766

HLA-A, B (Class I) and HLA-DR, DQ (Class II) Antigens in Turkish Patients with Recurrent Aphthous Ulceration and Behçet s Disease

767

HLA-A, -B and -DR Allele and Haplotype Frequencies in the European American, African American, and Hispanic Populations in Dallas, Texas: Relatedness to the North American Population

768

HLA-A, B, C, DR and DQ expression and hepatocellular carcinoma: study of 205 Italian subjects

769

HLA-A2.1/Kb Transgenic Murine Dendritic Cells Transduced with an Adenovirus Encoding Human gp100 Process the Same A2.1-Restricted Peptide Epitopes as Human Antigen-Presenting Cells and Elicit A2.1-Restricted Peptide-Specific CTL

770

HLA-B genotype and Escherichia coli association in Iraqi patients with reactive arthritis

771

HLA-B*1502 in Iranian Children with Anticonvulsant Drugs-Induced Skin Reactions

772

HLA-B27 and Ankylosing Spondylitis geographic distribution as the result of a genetic selection induced by malaria endemic? A review supporting the hypothesis

773

HLA-B27 antigen frequency among suspected Spondyloarthropathy patients attaining a tertiary level hospital of Bangladesh

774

HLA-B27 Association with Uveitis in an Asian Indian Population

775

HLA-B27 binding of peptide from its own sequence and similar peptides from bacteria: implications for spondyloarthropathies

776

HLA-B27 Subtypes Differentially Associated with Disease Exhibit Conformational Differences in Solution

777

HLA-B51 IN BEHÇET’S DISEASE

778

HLA-C polymorphisms in two cohorts of donors for bone marrow transplantation

779

HLA-Class II in Latin American patients with type 1 diabetes

780

HLA-Cw Allele Frequency in Definite Meniere’s Disease Compared to Probable Meniere’s Disease and Healthy Controls in an Iranian Sample

781

HLA-DM and the MHC Class II Antigen Presentation Pathway

782

HLA-DM, HLA-DO and tapasin: functional similarities and differences

783

HLA-DMB expression by thyrocytes: indication of thé antigen-processing and possible presenting capability of thyroid cells

784

HLA-DP Uyumsuzluğuna Bağlı Mikst Lenfosit Kültür Testindeki Pozitiflik

785

HLA-DPB1 Variant Effect on Hepatitis B Virus Clearance and Liver Cirrhosis Development Among Southwest Chinese Population

786

HLA-DQ Genotypes in Classic Type 1 Diabetes and in Latent Autoimmune Diabetes of the Adult

787

HLADQ2 and HLADQ8 Alleles Are Associated with Celiac Disease in Children

788

HLA-DQ8 is a predisposing molecule for detergent enzyme subtilisin BPN′-induced hypersensitivity

789

HLA-DQA and DQB Alleles and Predisposition to Insulin Dependent Diabetes Mellitus

790

HLA-DQA1 and -DQB1 Alleles as Risk Factors for Acute Lymphoblastic Leukemia

791

HLA-DR alleles among Pakistani patients of coeliac disease

792

HLA-DR Binding Prediction and Experimental Evaluation of T-Cell Epitopes of Mycolyl Transferase 85B (Ag85B), a Major Secreted Antigen of Mycobacterium tuberculosis

793

HLA-DR expression and lymphocytic infiltration in metastatic and non-metastatic papillary carcinoma of the thyroid

794

HLA-DR Polymorphism and Primary Biliary Cirrhosis: Evidence From a Meta-analysis

795

HLA-DR Typing by Polymerase Chain Reaction with Sequence- Specific Primers Compared to Serological typing

796

HLA-DR, ICAM-1, CD40, CD40L, and CD86 are incorporated to a similar degree into clinical human immunodeficiency virus type 1 variants expanded in natural reservoirs such as peripheral blood mononuclear cells and human lymphoid tissue cultured ex vivo

797

HLA-DR/DQ associations with rheumatic heart disease (RHD) in Mexicans

798

HLA-DRB and HLA-DQB Allele and Haplotype Frequencies in Iranian Patients with Recurrent Aphthous Stomatitis

799

HLA-DRB and HLA-DQB loci in the genetic uceptibility to develop glaucoma in Mexican Original Reearch Article

800

HLA‑DRB1 gene polymorphisms in Iranian children with Henoch‑Schönlein purpura

801

HLA-DRB1 leprogenic motifs in Nigerian population groups

802

HLA-DRB1 status affects endothelial function in treated patients with rheumatoid arthritis

803

HLA-DRB1*1301 AND *1302 protect against chronic hepatitis B

804

HLA-DRB1, DQA1 and DQB1 Alleles and Haplotypes Frequencies in Iranian Healthy Adult Responders and Non-Responders to Recombinant Hepatitis B Vaccine

805

HLA-DRβ1, Circulating Th1/Th2 Cytokines and Immunological Homunculus in Coronary Atherosclerosis

806

HLA-DRβ1, Circulating Th1/Th2 Cytokines and Immunological Homunculus in Coronary Atherosclerosis

807

HLA-DR1, Circulating Th1/Th2 Cytokines and Immunological Homunculus in Coronary Atherosclerosis

808

HLA-G allele and haplotype frequencies in a healthy population of Iran.

809

HLA-G and MIC expression in tumors and their role in anti-tumor immunity

810

HLA-G expression in trophoblast cells circulating in maternal peripheral blood during early pregnancy

811

HLA-G Expression Pattern: Reliable Assessment for Pregnancy Outcome Prediction

812

HLA-G in patients with pemphigus vulgaris: does it correlate with disease severity?

813

HLA-G protein concentrations in maternal serum and placental tissue are decreased in preeclampsia

814

HLA-G remains a mystery

815

HLA-G*0105N Null Allele Encodes Functional HLA-G Isoforms

816

HLA-G: a shield against inflammatory aggression

817

HLA-G: Facts and Fictions

818

HLA-G: from biology to clinical benefits

819

HLA-G1 increases the radiosensitivity of human tumoral cells

820

HLA-G5 and G7 Isoforms in Pregnant Women

821

HLA-H Mutations in the Ashkenazi Jewish Population

822

HLA-Ig-based artificial antigen-presenting cells: setting the terms of engagement

823

HLA-KIR Interactions and Immunity to Viral Infections

824

HLA-peptide tetrameric complexes

825

HLA-Promiscuous Th1-Cell Reactivity of MPT64 (Rv1980c), a Major Secreted Antigen of Mycobacterium tuberculosis, in Healthy Subjects

826

Hِlder conjugacies for random dynamical systems

827

Hِlder Exponent for a Two-Parameter Lévy Process

828

Hِlder regularity for non-divergence-form elliptic equations with discontinuous coefficients

829

Hِlder regularity for operator scaling stable random fields

830

Hِlder regularity for the gradients of solutions of the strong -Laplacian

831

Hِlder regularity for weak solutions to divergence form degenerate quasilinear parabolic systems

832

Hِlder type inequality for Sugeno integral

833

Hِlderian variational problems subject to integral constraints

834

HLHS With Severe Aortic Insufficiency in a Patient With 45,X/46,XY Mosaicism

835

HLI, A Direct Method Suitable for Partial and Fully Implicit Time Integration of Primitive Equation Meteorological Models

836

H-lifts of tangential k-blocks Original Research Article

837

HLLC solver for ideal relativistic MHD

838

HLLC-type Riemann solver for the Baer–Nunziato equations of compressible two-phase flow

839

HlLgm2, a member of asparaginyl endopeptidases/legumains in the midgut of the ixodid tick Haemaphysalis longicornis, is involved in blood-meal digestion

840

HLS RF cavity development in NSRL phase II project

841

HLS RF cavity development in NSRL phase II project

842

HLW glass dissolution in the presence of magnesium carbonate: Diffusion cell experiment and coupled modeling of diffusion and geochemical interactions

843

HMAC: An Enhanced Energy Efficient Protocol Design for Control Applications Using WSNS

844

HMAC-Based Authentication Protocol: Attacks and Improvements

845

HMB and Cp* ruthenium(II) complexes containing bis- and tris-(mercaptomethimazolyl)borate ligands: Synthetic, X-ray structural and electrochemical studies (HMB = η6-C6Me6, Cp* = η5-C5Me5)

846

HMB-45 Study Before and After Narrow-Band (311 nm) Ultraviolet B Treatment in Vitiligo

847

HMB-45 Study Before and After Narrow-Band (311 nm) Ultraviolet B Treatment in Vitiligo

848

HMB-45 Study Before and After Narrow-Band (311 nm) Ultraviolet B Treatment in Vitiligo

849

HMB-45 Study Before and After Narrow-Band (311 nm) Ultraviolet B Treatment in Vitiligo

850

HMB-45 Study Before and After Narrow-Band (311 nm) Ultraviolet B Treatment in Vitiligo

851

HMC algorithm with multiple time scale integration and mass preconditioning Original Research Article

852

HME: a Handheld Model Editor for Educational Contexts

853

H-measures and variants applied to parabolic equations

854

HMF sectors since 1926: Comparison of two ground-based data sets Original Research Article

855

HMG CoA reductase inhibitor (statin) and aortic valve calcium

856

HMG CoA reductase inhibitors are related to improved systemic endothelial function in coronary artery disease

857

HMGA2 expression in a canine model of prostate cancer

858

HMGA2 induces pituitary tumorigenesis by enhancing E2F1 activity

859

HMGA2 induces transcription factor Slug expression to promote epithelial-to-mesenchymal transition and contributes to colon cancer progression

860

HMGA2 is expressed in an allele-specific manner in human lipomas

861

HMGA2 overexpression in polycythemia vera with t(12;21)(q14;q22)

862

Hmga2 Promotes Neural Stem Cell Self-Renewal in Young but Not Old Mice by Reducing p16Ink4a and p19Arf Expression

863

HMGA2, MicroRNAs, and Stem Cell Aging

864

HMGA2–NFIB fusion in a pediatric intramuscular lipoma: a novel case of NFIB alteration in a large deep-seated adipocytic tumor

865

HMGA-targeted phosphorothioate DNA aptamers increase sensitivity to gemcitabine chemotherapy in human pancreatic cancer cell lines

866

HMGB Binding to DNA: Single and Double Box Motifs

867

HMGB1 expression by activated vascular smooth muscle cells in advanced human atherosclerosis plaques

868

HMGB-1 induces cell motility and α5β1 integrin expression in human chondrosarcoma cells

869

HMGB1: a two-headed signal regulating tumor progression and immunity

870

HMGB1: guiding immunity from within

871

HMGB1-stimulated human primary cardiac fibroblasts exert a paracrine action on human and murine cardiac stem cells

872

HMGB2 stabilizes p53 by interfering with E6/E6AP-mediated p53 degradation in human papillomavirus-positive HeLa cells

873

HMG-Co reductase inhibition by atorvastatin reduces neointimal inflammation in rabbit model of atherosclerosis

874

HMG-Co Reductase Inhibitors Decrease CD11b Expression and CD11b-Dependent Adhesion of Monocytes to Endothelium and Reduce Increased Adhesiveness of Monocytes Isolated From Patients With Hypercholesterolemi

875

HMG-Co reductase inhibitors reduce cerebral infarct size by upregulating endothelial nitric oxide synthase

876

HMG-CoA inhibitors induced the LDL oxidation

877

HMG-CoA reductase and ACAT inhibitors act synergistically to lower plasma cholesterol and limit atherosclerotic lesion development in the cholesterol-fed rabbit Original Research Article

878

HMG-CoA reductase inhibition improves anti-aging klotho protein expression and arteriosclerosis in rats with chronic inhibition of nitric oxide synthesis

879

HMG-CoA reductase inhibition improves endothelial cell function and inhibits smooth muscle cell proliferation in human saphenous veins

880

HMG-CoA reductase inhibitor enhances inducible nitric oxide synthase expression in rat vascular smooth muscle cells; involvement of the Rho/Rho kinase pathway

881

HMG-CoA reductase inhibitor improves endothelial dysfunction in mineralocorticoid hypertension by inhibition of RhoA

882

HMG-CoA reductase inhibitor therapy and stroke risk reduction: an analysis of clinical trials data Original Research Article

883

HMG-CoA reductase inhibitors induce apoptosis in neointima-derived vascular smooth muscle cells

884

HMG-CoA reductase inhibitors reduce vascular monocyte chemotactic protein-1 expression in early lesions from hypercholesterolemic swine independently of their effect on plasma cholesterol levels

885

HMG-CoA reductase inhibitors suppress macrophage growth induced by oxidized low density lipoprotein

886

HMG-CoA reductase inhibitors suppress maturation of human dendritic cells: new implications for atherosclerosis

887

HMG-CoA reductase inhibitors, gemfibrozil, and myopathy

888

HMGIC alterations in smooth muscle tumors of soft tissues and other sites

889

HMGI-C and HMGI(Y) expression in uterine leiomyomata: dysregulation of architectural factors in a benign neoplasm

890

HMGIC Expressed in a Uterine Leiomyoma with a Deletion of the Long Arm of Chromosome 7 Along with a 12q14–15 Rearrangement But Not in Tumors Showing del(7) as the Sole Cytogenetic Abnormality

891

HMM delay prediction technique for VoIP

892

HMM topology design using maximum likelihood successive state splitting

893

HMM-Based Gain Modeling for Enhancement of Speech in Noise

894

HMM-based handwritten word recognition: on the optimization of the number of states, training iterations and Gaussian components

895

HMM-based on-line signature verification: Feature extraction and signature modeling

896

HMM-based strategies for enhancement of speech signals embedded in nonstationary noise

897

HMM-based stressed speech modeling with application to improved synthesis and recognition of isolated speech under stress

898

Hmmmm Gardening Some Comments on Garden Style and False Economy

899

HMMPred: Accurate Prediction of DNA-Binding Proteins Based on HMM Profiles and XGBoost Feature Selection

900

HMM-separation-based speech recognition for a distant moving speaker

901

HMMSTR: a hidden Markov model for local sequence-structure correlations in proteins

902

HMO formularies and care costs

903

HMO formularies and care costs

904

HMO formularies lead to higher care costs

905

HMO penetration and the geographic mobility of practicing physicians

906

HMO physiciansʹ use of referrals

907

HMO stocks hit bad times, say analysts

908

H-mode barrier control with external magnetic perturbations

909

H-module endomorphism rings Original Research Article

910

H-mordenite zeolite as an efficient, rapid and recyclable catalyst for chemoselective synthesis of 1,1-diacetates under solvent-free conditions

911

H-Morph: an indirect approach to advancing front hex meshing

912

HMOs, market competition, and premium cost

913

HMOs, moral hazard and cost shifting in workersʹ compensation

914

HMPAO-SPECT imaging during intense Tibetan Buddhist meditation

915

HMS SCOTT ring laser gyro navigator integration

916

HMT assisted hydrothermal synthesis of various ZnO nanostructures: Structure, growth and gas sensor properties

917

HMT production and sublimation during thermal process of cometary organic analogs. Implications for its detection with the ROSETTA instruments

918

HMTTEF.C60-A 2-D close-packed layered compound of C60

919

h-Multigrid for space-time discontinuous Galerkin discretizations of the compressible Navier–Stokes equations

920

hMutSα is Protected from Ubiquitin-proteasome-dependent Degradation by Atypical Protein Kinase Cζ Phosphorylation

921

hMutSα is Protected from Ubiquitin-proteasome-dependent Degradation by Atypical Protein Kinase Cζ Phosphorylation Original Research Article

922

HMW1_555-914, HMW2_553-916, and Hia_585-705as Subunit Vaccine Candidates of Nontypeable Haemophilus influenzae Induce Specific Antibody Responses with Bactericidal Activity in Balb/c

923

HMX decomposition model to characterize thermal damage

924

HNE increases HO-1 through activation of the ERK pathway in pulmonary epithelial cells

925

HNF/HTPB propellants: Influence of HNF particle size on ballistic properties

926

HNF-1 alpha: have bile acid transport genes found their “master”?

927

HNF4α Antagonists Discovered by a High-Throughput Screen for Modulators of the Human Insulin Promoter Original Research Article

928

HNF-4α: from MODY to late-onset type 2 diabetes

929

HNN extensions of inverse semigroups and groupoids

930

HNN extensions of von Neumann algebras

931

HNN-Extensions of Finitely Presented Soluble Groups Original Research Article

932

HNN-Extensions of Finitely Presented Soluble Groups Original Research Article

933

HNO Detection by Nanosized B12N12 Cage: A DFT/TDDFT Study

934

HNO made-easy from photochemical cycloreversion of novel 3,5-heterocyclic disubstituted 1,2,4-oxadiazole-4-oxides

935

HNO3 analyzer by scrubber difference and the NO–ozone chemiluminescence method

936

HNO3 fluxes to a deciduous forest derived using gradient and REA methods

937

HNO3 losses within the cyclone inlet of a diffusion-denuder system under simulated marine environments

938

HNO3/H3PO4–NANO2 mediated oxidation of cellulose — preparation and characterization of bioabsorbable oxidized celluloses in high yields and with different levels of oxidation

939

HNO3/N,N-Diethylethanaminium-2-(Sulfooxy)Ethyl Sulfate as an Efficient System for the Regioselective of Aromatic Compounds

940

HNPCC mutations in hMSH2 result in reduced hMSH2-hMSH6 molecular switch functions

941

hnRNP K: An HDM2 Target and Transcriptional Coactivator of p53 in Response to DNA Damage

942

H-NS Oligomerization Domain Structure Reveals the Mechanism for High Order Self-association of the Intact Protein

943

hNηN final-state interaction in incoherent photoproduction of hη -mesons from the deuteron

944

HO in pregnancy,

945

Ho Sok Fong, Lake Like a Mirror: Stories.Translated from the Chinese by Natascha Bruce. London:Granta, 2019. 199pp. ISBN:9781846276903

946

H–O, S and Pb isotope geochemistry of the Awanda gold deposit in southern Tianshan, Central Asian orogenic belt: Implications for fluid regime and metallogeny

947

HO∴OH−: a model for stable three-electron bonded peroxide radical anions

948

HO-1 and VGEF gene expression in human arteries with advanced atherosclerosis

949

HO-1 induction attenuates renal damage and oxidative stress induced by K2Cr2O7

950

HO-1 pharmacological over-expression in a rat model of Type II diabetes: implications for microvascular tone and the genesis of ischemia

951

Ho3+ carbon paste sensor based on multi-walled carbon nanotubes: Applied for determination of holmium content in biological and environmental samples

952

Ho3+ sensitized upconverted emission from Er3+ doped TeO2 glass system

953

Ho3+: (5S2,5F4)→5I5 transition in fluoride glasses

954

Hoàng–Reed conjecture holds for tournaments

955

Hoarding and its relation to obsessive–compulsive disorder

956

Hoarding behaviors in a large college sample

957

Hoarding habitat selection of squirrels (Sciurus vulgaris) in Liangshui Nature Reserve, China

958

Hoarding in a compulsive buying sample

959

Hoarding in obsessive compulsive disorder: results from a case-control study

960

Hoarding in obsessive–compulsive disorder: Results from the OCD Collaborative Genetics Study

961

Hoarding, compulsive buying and reasons for saving

962

Hoarse cry: a sign of dehydration

963

Hoarseness after cardiac operations: Vocal cord paralysis or a conversion disorder?

964

Hoarseness as a Sign of Possible Nonspecific Mucosal Hyperreactivity in Vocal Tract

965

Hoarseness as Presenting Complain of a Glomus Vagale

966

HOARSENESS AS PRESENTING SYMPTOM OF PEDIATRIC LARYNGEAL AMYLOIDOSIS

967

Hoarseness as the Presenting Symptom of Visceral Leishmaniasis with Muco-Cutaneous Lesions: A Case Report.

968

Hoarseness Due to Bamboo Nodes in Patients with Autoimmune Diseases: A Review of Literature

969

Hoarseness of Voice Due to Ipsilateral Recurrent Laryngeal Nerve Palsy in Ultrasound Guided Right Sided Supraclavicular Brachial Plexus Block: A Case Report

970

Hob: a New Tool for Tracking and IncreasingValueAdded

971

Hobbes and Hume in relation to Kant

972

Hobbits, Hogwarts, and the Heavens: The use of fantasy literature and film in astronomy outreach and education

973

Hobbs Coast Cenozoic volcanism: Implications for the West Antarctic rift system

974

Hobbsʹ Food Poisoning and Food Hygiene, 7th edition, Jim McLauchlin, Christine Little (Eds.). Hudder Arnold (2007)

975

Hobbs’ Food Poisoning and Food Hygiene. 7th Edition, Edited by Jim McLaughlin and Christine Little, Hodder Arnold, 2007, ISBN: 978 034 090 5302 (PB), Price £19. 99

976

Hobermanʹs Sphere, Euler Parameters and Lagrangeʹs Equations

977

Hobomok, A Tale of Early Times as a Lieu de Memoire: Revising the Image of the Puritans and the History of Early New England

978

HOBt and HOAt-derived immonium salts: new and highly efficient coupling reagents for peptide synthesis

979

Hochschild (2003) — The managed heart: The recognition of emotional labour in public service work

980

Hochschild (Co)homology and Derived Categories

981

HOCHSCHILD (CO)HOMOLOGY DIMENSION

982

Hochschild (Co)Homology of Differential Operator Rings,

983

Hochschild and cyclic homology of the quantum multiparametric torus Original Research Article

984

Hochschild cohomology and “smoothness” in monoidal categories

985

Hochschild cohomology and derived Picard groups

986

Hochschild cohomology and Linckelmann cohomology for blocks of finite groups

987

Hochschild Cohomology and the Coradical Filtration of Pointed Coalgebras: Applications

988

Hochschild cohomology is topological

989

Hochschild cohomology of abelian categories and ringed spaces

990

Hochschild cohomology of incidence algebras as one-point extensions Original Research Article

991

Hochschild Cohomology of Minimal Hereditary Orders Original Research Article

992

Hochschild Cohomology of Minimal Hereditary Orders Original Research Article

993

Hochschild cohomology of quasiprojective schemes Original Research Article

994

Hochschild cohomology of tame blocks

995

Hochschild Cohomology of Triangular Matrix Algebras,

996

Hochschild cohomology on Hopf Galois extensions Original Research Article

997

Hochschild Cohomology, Monoid Objects and Monoidal Categories

998

Hochschild duality, localization, and smash products

999

Hochschild homology and cohomology of some classical and quantum noncommutative polynomial algebras

1000

Hochschild–Mitchell cohomology and Galois extensions

بازگشت